Triphase Accelerator is a privately held drug development accelerator that acquires and develops novel therapeutics.
Business Model:
Revenue: $0
Employees: 0-0
Address: 661 University Ave Suite 415
City: Toronto
State: ontario
Zip: M5G 1M1
Country: CA
Triphase Accelerator is a privately held drug development accelerator that acquires and develops novel therapeutics. Triphase in-licenses clinically enabled oncology assets with high-value potential and develops them in a shared risk model to proof of concept (POC), then out-licenses or sells the product to realize value. Triphase has formed a strategic partnership with Celgene Corporation to enable the rapid development of proof of concept in important new cancer therapeutics of mutual interest. The Triphase management team is deeply knowledgeable with significant experience in drug development. Together with the founding organizations Ontario Institute of Cancer Research (OICR) and MaRS Innovation, and supported by MaRS Discovery District along with strategic oncology partnerships, Triphase has formed a unique partnership to produce proof-of-concept data for investors, partners, regulators, payers, and ultimately prescribers and patients.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Name | Price |
---|
Name | Size | Announced Date |
---|